Resonance Health Limited (ASX:RHT)

Resonance Health Revenue

In the fiscal year ending June 30, 2026, Resonance Health had annual revenue of 15.75M AUD with 42.25% growth. Resonance Health had revenue of 7.78M in the half year ending June 30, 2026, with 46.07% growth. That makes Resonance Health the 36,884th largest company in the world by revenue and 661st in Australia.

• Revenue: 15.75M
• Revenue Growth: +42.25%
• P/S Ratio: 2.21
• Revenue / Employee: 984.49K
• Employees: 16
• Market Cap: 34.35M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Resonance Clinical 7.54M 40.3%
• SaMD (Including Research & Development ) 7.04M 37.6%
• Trialswest 4.15M 22.1%

By Geography

Chart

• Asia/Pacific 10.07M 63.9%
• North America 3.93M 24.9%
• EMEA 1.75M 11.1%

Fiscal year ended Jun 30, 2026 See the full Resonance Health breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	15.75M	4.68M	42.25%
Jun 30, 2025	11.07M	2.48M	28.91%
Jun 30, 2024	8.59M	4.19M	95.02%
Jun 30, 2023	4.40M	551.38K	14.31%
Jun 30, 2022	3.85M	74.06K	1.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 18, 2026

Data Sources Report a data error